BASF’s, Earnings

BASF’s Earnings Beat Fails to Convince as Cash Flow Squeeze and Geopolitical Clouds Persist

Published on 07/16/2026 at 15:56 | Redaktion boerse-global.de

BASF smashes Q2 forecasts with €3.9B gain, but stock dips on unchanged free cash flow outlook and rising geopolitical risks around the Strait of Hormuz.

BASF Q2 Earnings Beat Forecasts, but Free Cash Flow Guidance Disappoints
BASF’s Earnings Beat Fails to Convince as Cash Flow Squeeze and Geopolitical Clouds Persist Illustration mit AI erstellt übermittelt durch boerse-global.de

BASF delivered a blockbuster second quarter that smashed analyst forecasts, driven by higher prices, stronger volumes, and a €3.9 billion pre-tax gain from the sale of its Coatings business to Carlyle. Yet the stock edged lower on the day of the release – a clear sign that investors are looking past the headline numbers to the company’s unchanged free cash flow guidance and the gathering geopolitical storm around the Strait of Hormuz.

Revenue jumped 16% to €17.2 billion, comfortably above the €16.5 billion consensus. Underlying EBITDA before special items came in at €2.4 billion, well ahead of the €2.1 billion average estimate and up sharply from €1.6 billion a year earlier. Net income soared to €4.1 billion from just €79 million, though that leap is almost entirely attributable to the Coatings divestiture, which closed on June 30. Without that one-off, the operational picture, while solid, would have looked far less spectacular.

The market’s disappointment centers on cash flow. BASF raised its full-year EBITDA forecast to a range of €6.9 billion to €7.7 billion, up from €6.2 billion to €7.0 billion, placing the analyst consensus of €7.3 billion comfortably inside the new band. But the free cash flow outlook remained stuck at €1.5 billion to €2.3 billion. In the second quarter, free cash flow swung to minus €0.2 billion from plus €0.5 billion a year ago, as rising raw material costs tied up more working capital. Analysts had hoped for an upgrade here; the unchanged guidance signals that higher costs are eroding some of the profit gains.

That caution is echoed by institutional observers. JPMorgan’s Chetan Udeshi, who continues to list BASF on his “Negative Catalyst Watch” ahead of the half-year report on July 29, kept an Underweight rating. He argues that while geopolitical tensions provide short-term tailwinds for cyclical names like BASF, structural overcapacity – particularly in China – and high cost pressures at European plants remain longer-term drags.

Should investors sell immediately? Or is it worth buying BASF?

Geopolitical uncertainty is front and centre in BASF’s own outlook. The company explicitly cited the Strait of Hormuz as a risk factor for the second half, warning that a prolonged closure would severely disrupt global economic activity. BASF has already raised its assumed Brent oil price for 2026 from $65 to $80 per barrel, while trimming its expectations for GDP, industrial production, and chemical output growth. The revised oil price, the company notes, may represent the floor of the risk rather than the ceiling.

Technically, the stock has some support. At Thursday’s close of €48.35 (a slight recovery from the previous day’s dip), it sits just 1.1% above its 200-day moving average of €47.54 and 3.4% below the 50-day average of €49.76. The RSI of 46.7 is neutral. From its November 2025 low of €41.60, the share price has recovered about 15%, and year to date it is up 7.4%. The 52-week high of €55.05 offers a potential upside target if the situation stabilises.

A positive scenario hinges on a easing of tensions around the Strait of Hormuz. That could quickly lift the veil of low visibility that BASF itself flagged, allowing the company’s operational improvements and ongoing restructuring programme to shine through. A more bearish path would see the stock range-bound between the 200-day and 50-day averages, with the skeptics – including JPMorgan – proving right that structural problems outweigh cyclical strength.

BASF at a turning point? This analysis reveals what investors need to know now.

Amid the macro angst, BASF also opened a new specialty emollients plant in DĂĽsseldorf on July 16, a modest but strategic addition to its consumer care business. The next concrete catalyst is the half-year report on July 29, when investors will look for confirmation of the raised guidance and, more importantly, a clearer read on how the company assesses the risks for the remainder of the year.

Ad

BASF Stock: New Analysis - 16 July

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000BASF111 | BASF’S | boerse | 69780726 |